|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| Pharmacogenetics: From Bench to Bedside | ||||||||||||||||
| July 02, 2002 | ||||||||||||||||
|
The New York Academy of Medicine, 1216 Fifth Avenue at 103rd street, New York City October 3-4, 2002 THURSDAY, OCTOBER 3, 2002 8:30 Registration/Breakfast 9:00 Welcome & Introduction to the Symposium Harry Ostrer, MD, Professor of Pediatrics, Pathology, and Medicine; Director, Human Genetics Program New York University School of Medicine Keynote I Daniel Cohen, MD, PhD, Scientific Director, Genset, Paris, France From Linkage to Causative Pathways 10:20 Break 10:40 SESSION I –IDENTIFYING DRUG RESPONSE GENES Moderator: Harry Ostrer, MD Nicholas J. Schork, PhD, Professor, Dept. of Psychiatry, University of California, San Diego Statistical Methods for Pharmacogenetic Analysis Lawrence M. Gelbert, PhD, Research Scientist, Group Leader, Functional Genomics Eli Lilly & Company Drug Discovery in the Post-Human Genome Era 12:40 Lunch 2:00 SESSION II –DETERMINING GENE FUNCTION AND THERAPEUTIC UTILITY Moderator: David A Flockhart MD, PhD David A Flockhart MD, PhD, Professor of Medicine and Pharmacology Division of Clinical Pharmacology, Indiana University School of Medicine Applications of Pharmacogenomics in Clinical Practice Mihael Polymeropoulos, MD V.P. & Head of the Pharmacogenetics Dept. Novartis Pharmaceuticals Corporation Genetics in Medical Practice Daniel T. O'Connor, M.D., Professor of Medicine and Director of Hypertension UCSD and VA San Diego Health Care System Pharmacogenetics and Autonomic Control of the Circulation 5:00 Reception FRIDAY, OCTOBER 4, 2002 8:30 Breakfast 9:00 Welcome & Introduction David A Flockhart MD, PhD Keynote II Alastair J.J. Wood MD, Assistant Vice Chancellor for Research Vanderbilt University Will We Prescribe by Genotype? 10:00 SESSION III –POPULATION GENETICS AND PHARMACOGENOMICS Moderator: Nadine Cohen, PhD, Head of Pharmacogenomics, Johnson & Johnson Pharmaceutical Research & Development David B. Goldstein, PhD, Wolfson Professor of Genetics, University College of London Population Structure, Linkage Disequilibrium and the Genetic Basis of Variable Drug Response Hákon Hákonarson, M.D., PhD, Chief Scientific Officer, DeCode, Inc., Reykjavik, Iceland Bridging the Gap Between Gene Expression and Population Genomics: The Genealogical Approach to Pharmacogenomics Leena Peltonen, M.D., Ph.D., Professor and Chair, Department of Human Genetics UCLA School of Medicine Tracking Rare and Common Disease Genes Using Isolated Populations 11:10 Break 11:30 SESSION IV –REGULATORY AND ETHICAL IMPLICATIONS IN PHARMACOGENETICS Moderator: Alan R. Fleischman, MD, Senior Vice President, New York Academy of Medicine Mark A. Rothstein, JD, Herbert F. Boehl Chair of Law and Medicine; Director, Institute for Bioethics, Health Policy and Law, University of Louisville School of Medicine Ethics & Public Attitudes in Pharmacogenomics Policy Nadine Cohen, PhD, Head of Pharmacogenomics Johnson & Johnson Pharmaceutical Research and Development Elements of Informed Consent for Pharmacogenetic Research: Perspective of the Pharmacogenetics Working Group N.A.M. Atiqur Rahman, PhD Team Leader Center for Drug Evaluation and Research Food and Drug Administration Pharmacogenetics: Regulatory Consideration in Drug Development & Drug Approval (A Clinical Pharmacology Perspective) SESSION V -CLINICAL APPLICATIONS Moderator: Brian Spear, PhD, Director, Pharmacogenetics Abbott Laboratories Howard McLeod, PharmD, Associate Professor, Department of Medicine Washington University Pharmacogenetics of Anticancer Agents Andrew Dorner, PhD, Director, Molecular Medicine and Pharmacogenomics Wyeth Research Pharmacogenetics in Phase I/II Clinical Trials: Application of Expression Profiling in Clinical Testing Julie A. Johnson, PharmD, FCCP, BCPS, Professor, Pharmacy Practice University of Florida Pharmacogenetics of Cardiovascular Drugs 1:30 Adjourn |
||||||||||||||||
| Organized by: | Harry Ostrer, MD; David Flockhart, Md, PhD; Nadine Cohen, PhD | |||||||||||||||
| Invited Speakers: | Keynote Speakers: Daniel Cohen, MD, PhD, Scientific Director, Genset, France Alastair J.J. Wood, Assistant Vice Chancellor for Research, Vanderbilt University |
|||||||||||||||
| Deadline for Abstracts: | n/a | |||||||||||||||
| Registration: | Registration: Regular Tuition $200 NYAM Fellows $160 Residents/Students/Post-Doctoral fellows $50 |
|||||||||||||||
| E-mail: | jflecha@nyam.org | |||||||||||||||
| Posted by: | Janice Flecha | |||||||||||||||
| Host: | 205.232.35.3 | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||